Main points Therapeutic strategy Clinical data
NICE does not recommend chlormethine gel to treat T-cell lymphoma
Figure 1, Model Structure - Chlormethine Gel (Ledaga) - NCBI Bookshelf
Ledaga recommended by NICE for rare type of lymphoma - PharmaTimes
LEDAGA 160MCG/G GEL 60G | Apotheek André Dumont
Clinical Review - Chlormethine Gel (Ledaga) - NCBI Bookshelf
Ledaga, INN- chlormethine
Ledaga Consumer Information – English
Ledaga, INN- chlormethine
Homocystinuria and its treatment
Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports | Advances in Therapy
Fiche Information Patient LEDAGA® (Chlorméthine)
Ledaga Consumer Information – English
Clinical Review - Chlormethine Gel (Ledaga) - NCBI Bookshelf
1 Helsinn announces publication of latest mechlorethamine gel research, highlighting its efficacy and safety Lugano, Switzerlan
View of Chlormethine Gel (Ledaga) | Canadian Journal of Health Technologies
Actelion gets EU Approval to Launch a Treatment for a Rare Skin Cancer | Biopharma Business
Chlormethine Gel (Ledaga) | Canadian Journal of Health Technologies
The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region) - Assaf - 2022 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library
Juniper Biologics signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East
Actelion is Granted Marketing Authorization by the European Commission for Ledaga (Chlormethine Gel) for the Treatment
Clinical Review - Chlormethine Gel (Ledaga) - NCBI Bookshelf
Chlormethine Gel (Ledaga) - NCBI Bookshelf
